Texas Senate Bill SB277

Texas 2021 - 87th Regular

Caption

Relating to health benefit plan coverage of epinephrine auto-injectors for certain individuals.

Impact

The enactment of SB277 is expected to amend Chapter 1367 of the Insurance Code by introducing a new subchapter specifically addressing epinephrine auto-injectors. It ensures that health plans cannot deny coverage for these devices when deemed medically necessary for covered individuals. By specifying that coverage extends to numerous types of health plans, including Medicaid, the bill enhances the safety and treatment of young allergic patients across Texas.

Summary

Senate Bill 277 focuses on the health benefit plan coverage of epinephrine auto-injectors for individuals 18 years of age or younger. The bill mandates that health benefit plans, including various types of insurance policies, must provide coverage for the cost of medically necessary epinephrine auto-injectors. This requirement aims to improve access to potentially life-saving medication for young individuals at risk of anaphylaxis, a severe allergic reaction.

Contention

While the coverage for epinephrine auto-injectors is largely supported for its potential to save lives, discussions may arise regarding the cost implications for insurance providers and how these costs might affect premiums. There could also be debates on the adequacy of insurance companies’ compliance with the new requirements, as health plans adapt to the changes mandated by the bill. Overall, the focus remains on balancing insurance sustainability with the healthcare needs of vulnerable populations.